SOPHIA ANTIPOLIS, France – November 05, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. AGS Therapeutics: Pioneering Microalgae-Based Drug Delivery for Therapeutic mRNA AGS therapeutic, a French newcomer to follow Identified[…]
SOPHIA ANTIPOLIS, France – November 04, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Circular RNAs present advantages over conventional therapeutics mRNAs Circular RNA (circRNA) is a unique type of single-stranded[…]
SOPHIA ANTIPOLIS, France – September 03, 2024 │ The last quarterly report for the 2024 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Monkeypox virus, a new threat? Mpox, also known as monkeypox, is a viral disease caused by the[…]
SOPHIA ANTIPOLIS, France – January 16, 2024 │ The last quarterly report for the 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. As we leave behind another year, we look back on the mRNA therapeutic patenting activity! Q4 2023[…]